Metabolic syndrome.

Can J Cardiovasc Nurs

Queen Elizabeth II Health Sciences Centre, Room 6248, 1796 Summer Street, Halifax Nova Scotia.

Published: July 2005

AI Article Synopsis

Article Abstract

Cardiovascular disease (CVD) and diabetes are growing public health burdens and remain one of the leading causes of morbidity and mortality in Canada (Heart and Stroke Foundation, 2003). It has become increasingly evident that individuals who present with a cluster of metabolic disorders, known as the metabolic syndrome, are at an increased risk of developing both CVD and type 2 diabetes (Ng, 2003). Due to the increased risk of morbidity and mortality associated with the metabolic syndrome, it is imperative for health care professionals to become familiar with the diagnostic criteria for this disorder. This will enable nurses to provide the appropriate primary and secondary prevention strategies in order to help reduce individual risk. With the help of a case study, this article will define metabolic syndrome, review its prevalence and risk factors, and discuss therapeutic interventions for this disorder.

Download full-text PDF

Source

Publication Analysis

Top Keywords

metabolic syndrome
16
morbidity mortality
8
increased risk
8
metabolic
5
syndrome cardiovascular
4
cardiovascular disease
4
disease cvd
4
cvd diabetes
4
diabetes growing
4
growing public
4

Similar Publications

Protective effects of herbal compounds against cyclophosphamide-induced organ toxicity: a pathway-centered approach.

Drug Chem Toxicol

January 2025

Department of Biotechnology, School of Biosciences and Technology, VIT University, Vellore, India.

Cyclophosphamide is a key component of numerous chemotherapeutic protocols, demonstrating broad-spectrum efficacy against various malignancies and non-cancerous conditions. This review examines CPM's metabolic pathways, therapeutic applications, and its resulting organ-specific toxicities. Despite its clinical benefits in treating nephrotic syndrome, encephalomyelitis, breast cancer, ovarian cancer, and other diseases, CPM is associated with significant adverse effects on the kidneys, liver, heart, lungs, and intestines.

View Article and Find Full Text PDF

Unlabelled: One of the principles of prevention and non-drug treatment of liver diseases, including hepatitis of various etiologies, is the normalization of the diet, including the use of daily diet foods with physiologically active ingredients, in particular betulin, which helps to reduce metabolic and oxidative processes within liver cells. The aim of the work was to evaluate the in vivo effect of triterpene alcohol betulin Roth isolated from the bark of birch Betula pendula Roth. added to fat-containing products (for example, mayonnaise) on the biochemical parameters of blood and the morphological structure of the liver of rats with initiated acute toxic hepatitis.

View Article and Find Full Text PDF

Purpose Of Review: To provide a narrative overview of trends and disparities in the cardiometabolic profiles of U.S. adults by synthesizing findings from nationally representative studies conducted between 1999 and 2020.

View Article and Find Full Text PDF

Context: The medications for metabolic syndromes are very minimal and the available are not effective and show adverse effects. There is a huge need for the development of effective and safe drugs to battle metabolic syndromes. In this context, our study aimed to decipher the key molecules from Artocarpus communis seed hexane fraction and their possible mechanism of action against metabolic syndrome.

View Article and Find Full Text PDF

This study aimed to evaluate the comparative efficacy of Myo-inositol (MI) and D-chiro-inositol (DCI) with metformin in enhancing ovarian function, promoting ovulation, and reducing perceived stress in patients with polycystic ovary syndrome (PCOS). Women with PCOS were identified using the Androgen Excess Society's criteria, and 60 participants were enrolled and divided equally into two groups. One group received a 40:1 ratio of MI plus DCI, while the other received metformin for a 12-week period.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!